These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37799010)

  • 1. The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID-19 in the capital region of Denmark.
    Kliim-Hansen V; Johansson KS; Gasbjerg LS; Jimenez-Solem E; Petersen TS; Nyeland ME; Winther-Jensen M; Ankarfeldt MZ; Pedersen MG; Ellegaard AM; Knop FK; Christensen MB
    Diabetes Obes Metab; 2024 Jan; 26(1):160-168. PubMed ID: 37799010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis.
    Klonoff DC; Messler JC; Umpierrez GE; Peng L; Booth R; Crowe J; Garrett V; McFarland R; Pasquel FJ
    Diabetes Care; 2021 Feb; 44(2):578-585. PubMed ID: 33323475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated haemoglobin levels among 3295 hospitalized COVID-19 patients, with and without diabetes, and risk of severe infection, admission to an intensive care unit and all-cause mortality.
    Alhakak A; Butt JH; Gerds TA; Fosbøl EL; Mogensen UM; Krøll J; Pallisgaard JL; Gislason GH; Torp-Pedersen C; Køber L; Weeke PE
    Diabetes Obes Metab; 2022 Mar; 24(3):499-510. PubMed ID: 34779086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years.
    Gotfredsen DR; Vinther S; Petersen TS; Cortes R; Jensen TB; Jimenez-Solem E; Christensen MB
    Sci Rep; 2020 Mar; 10(1):4095. PubMed ID: 32139733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline haemoglobin A1c and the risk of COVID-19 hospitalization among patients with diabetes in the INSIGHT Clinical Research Network.
    Min JY; Williams N; Simmons W; Banerjee S; Wang F; Zhang Y; Reese AB; Mushlin AI; Flory JH
    Diabet Med; 2022 May; 39(5):e14815. PubMed ID: 35179807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
    Charoenngam N; Alexanian SM; Apovian CM; Holick MF
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.
    Chang YL; Sheu WH; Lin SY; Liou WS
    Clin Exp Med; 2018 Aug; 18(3):383-390. PubMed ID: 29572669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19.
    McDonnell ME; Garg R; Gopalakrishnan G; Mitri J; Weinstock RS; Greenfield M; Katta S; Lebastchi J; Palermo NE; Radhakrishnan R; Westcott GP; Johnson M; Simonson DC
    J Clin Endocrinol Metab; 2023 Feb; 108(3):718-725. PubMed ID: 36217580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19.
    Riahi S; Sombra LRS; Lo KB; Chacko SR; Neto AGM; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J; Anastasopoulou C
    Endocr Res; 2021; 46(2):45-50. PubMed ID: 33275067
    [No Abstract]   [Full Text] [Related]  

  • 12. Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data.
    Kristófi R; Bodegard J; Ritsinger V; Thuresson M; Nathanson D; Nyström T; Norhammar A; Eriksson JW
    Cardiovasc Diabetol; 2022 Dec; 21(1):282. PubMed ID: 36522650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia.
    Kim SH; Kim JY; Kim ES; Park IR; Ha EY; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
    Ann Med; 2022 Dec; 54(1):2736-2743. PubMed ID: 36205625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pre-existing type 2 diabetes with and without cardiovascular disease on patients with COVID-19.
    Nguyen C; Crowe CL; Kuti E; Narsipur N; Donato B; Pepe RS; Djaraher R; Seman L; Graeter N; Power TP; Mehra R; Willey VJ
    Diabetes Obes Metab; 2023 Sep; 25(9):2464-2472. PubMed ID: 36999236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
    Pérez-Belmonte LM; Torres-Peña JD; López-Carmona MD; Ayala-Gutiérrez MM; Fuentes-Jiménez F; Jorge Huerta L; Muñoz JA; Rubio-Rivas M; Madrazo M; Garcia MG; Montes BV; Sola JF; Ena J; Ferrer RG; Pérez CM; Ripper CJ; Lecumberri JJN; Acedo IEA; Canteli SP; Cosío SF; Martínez FA; Rodríguez BC; Pérez-Martínez P; Ramos-Rincón JM; Gómez-Huelgas R;
    BMC Med; 2020 Nov; 18(1):359. PubMed ID: 33190637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.
    Tong L; Khani M; Lu Q; Taylor B; Osinski K; Luo J
    Obes Res Clin Pract; 2023; 17(1):47-57. PubMed ID: 36577559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Metformin, Dipeptidyl Dipeptidase-4 Inhibitors, and Insulin with Coronavirus Disease 2019-Related Hospital Outcomes in Patients with Type 2 Diabetes.
    Obiri-Yeboah D; Bena J; Alwakeel M; Buehler L; Makin V; Zhou K; Pantalone KM; Lansang MC
    Endocr Pract; 2023 Sep; 29(9):681-685. PubMed ID: 37301375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in determinants of ICU admission and death among COVID-19 hospitalized patients in two epidemic waves in Portugal: possible impact of healthcare burden and hospital bed occupancy on clinical management and outcomes, March-December 2020.
    Ricoca Peixoto V; Vieira A; Aguiar P; Carvalho C; Thomas D; Sousa P; Nunes C; Abrantes A
    Front Public Health; 2023; 11():1215833. PubMed ID: 37501943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac adipose tissue volume assessed by computed tomography is a specific and independent predictor of early mortality and critical illness in COVID-19 in type 2-diabetic patients.
    Charpentier E; Redheuil A; Bourron O; Boussouar S; Lucidarme O; Zarai M; Kachenoura N; Bouazizi K; Salem JE; Hekimian G; Kerneis M; Amoura Z; Allenbach Y; Hatem S; Jeannin AC; Andreelli F; Phan F;
    Cardiovasc Diabetol; 2022 Dec; 21(1):294. PubMed ID: 36587209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.